Coronary disease & ACS

Prognostic Value of Plaque Volume in Patients With First Diagnosis of Coronary Artery Disease: A Substudy of the PROMISE Randomized Clinical Trial

JAMA CardiolPublished Secondary analysis of a randomised trial

Authors' conclusion

In symptomatic patients without known CAD, coronary plaque volumes and burdens are low but are related to CAD risk factors and independently predictive of MACE.

Study context

Population
Symptomatic outpatients without known coronary artery disease (CAD) randomised to coronary computed tomographic angiography (CCTA)
Participants
4,267 outpatients
Comparison
Quantitative CCTA plaque measures as predictors of MACE
Primary endpoint
MACE:
  • Death
  • Nonfatal MI
  • Hospitalization for unstable angina
Methodological detailspost hoc analysis, multicentre (193 sites, North America), Trial conducted July 27, 2010, to October 31, 2014; data analyzed January 2021 to July 2024
  • Post hoc analysis
  • Multicentre (193 sites, North America)
  • Trial conducted July 27, 2010, to October 31, 2014; data analyzed January 2021 to July 2024

Primary result

As reported in the abstract

MACE
Adjusted hazard ratio (95% CI)P value
TPBcontinuous; adjusted for clinical risk factors, statin use, qualitative CCTA findings
1.18(1.05–1.34)
P = 0.006
NCPBcontinuous; adjusted for clinical risk factors, statin use, qualitative CCTA findings
1.20(1.05–1.37)
P = 0.007
TPV ≥87 mm3optimal cutoff
2.07(1.24–3.49)
TPB ≥35%optimal cutoff
1.96(1.21–3.17)
NCPB ≥20%optimal cutoff
1.77(1.12–2.82)

Further findings

Total plaque volume (TPV)

Median (IQR) TPV
39.8 mm3 (0-167) mm3

Characteristics by TPV ≥ median vs < median

Mean (SD) age, years
62.1 [8.4] vs 58.7 [7.5]
Male
1286/2133 [60.3%] vs 782/2134 [36.6%]
Median (IQR) ASCVD risk score
14.4 [8.8-24.0] vs 7.9 [4.5-13.4]
  • Total plaque burden (TPB) showed similar demographic associations

Original publication

Prognostic Value of Plaque Volume in Patients With First Diagnosis of Coronary Artery Disease: A Substudy of the PROMISE Randomized Clinical Trial. JAMA Cardiol. Published 1 March 2026. doi:10.1001/jamacardio.2025.5520

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.